Eleonora Orloff

Principal Investigator Mi Sight 1 Day Safety Post- Approval Study at CooperVision

Eleonora Orloff is a seasoned optometrist and consultant, currently serving as a Consultant at Standard Practice and a Principal Investigator for the Mi Sight 1-Day Safety Post-Approval Study at CooperVision. As a co-founder of TearDx, Eleonora focuses on unlocking the diagnostic potential of tear fluid. At Bronx Eye Associates, a practice co-founded by Eleonora, a full scope optometric practice is managed, which specializes in various areas including refractive corrections and ocular disease management. In addition to practical experience, Eleonora has academic roles as a Clinical Associate Professor at Interamerican University of Puerto Rico and previously as an Assistant Clinical Professor at SUNY College of Optometry. Eleonora has pursued extensive education at reputable institutions, including a Master of Science candidate degree at Harvard Medical School and an Executive MBA from Harvard Business School.

Location

New York, United States

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


CooperVision

8 followers

CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world’s leading manufacturers of soft contact lenses. The Company produces a full array of monthly, two-week, and daily disposable contact lenses, all featuring advanced materials and optics.


Industries

Employees

5,001-10,000

Links